CIK 0001557746 · Non-accelerated filer<br>Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460571712
- Phone
- 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-01 | Gordon David N. Chief Medical Officer | Sale | −4,885 | $23.57 | $115K | 181,992 |
| 2021-06-01 | Gordon David N. Chief Medical Officer | Option exercise · Restricted Stock Units | −87,500 | 0 | ||
| 2021-06-01 | Ali-Jackson Kamil Chief Legal Officer | Option exercise | +33,189 | 176,807 | ||
| 2021-06-01 | Ali-Jackson Kamil Chief Legal Officer | Sale | −9,746 | $22.72 | $221K | 167,061 |
| 2021-06-01 | Ali-Jackson Kamil Chief Legal Officer | Sale | −5,254 | $23.57 | $124K | 161,807 |
| 2021-06-01 | Ali-Jackson Kamil Chief Legal Officer | Option exercise · Restricted Stock Units | −33,189 | 0 | ||
| 2021-06-01 | Monahan Joseph Chief Scientific Officer | Option exercise | +50,000 | 107,132 | ||
| 2021-06-01 | Monahan Joseph Chief Scientific Officer | Option exercise · Restricted Stock Units | −50,000 | 0 | ||
| 2021-06-01 | Ruffo Frank Chief Financial Officer | Option exercise | +33,189 | 184,909 | ||
| 2021-06-01 | Ruffo Frank Chief Financial Officer | Option exercise · Restricted Stock Units | −33,189 | 0 | ||
| 2021-06-01 | Walker Neal President and CEO | Option exercise | +73,015 | 1,265,442 | ||
| 2021-06-01 | Walker Neal President and CEO | Option exercise · Restricted Stock Units | −73,015 | 0 | ||
| 2021-05-07 | Ali-Jackson Kamil Chief Legal Officer | Option exercise | +5,416 | $10.66 | $58K | 149,034 |
| 2021-05-07 | Ali-Jackson Kamil Chief Legal Officer | Sale | −3,316 | $23.23 | $77K | 145,718 |
| 2021-05-07 | Ali-Jackson Kamil Chief Legal Officer | Sale | −2,100 | $23.99 | $50K | 143,618 |
| 2021-05-07 | Ali-Jackson Kamil Chief Legal Officer | Option exercise · Employee Stock Option (Right to Buy) | −5,416 | 0 | ||
| 2021-05-06 | Ali-Jackson Kamil Chief Legal Officer | Option exercise | +15,000 | $10.66 | $160K | 158,618 |
| 2021-05-06 | Ali-Jackson Kamil Chief Legal Officer | Sale | −11,898 | $23.32 | $277K | 146,720 |
| 2021-05-06 | Ali-Jackson Kamil Chief Legal Officer | Sale | −3,102 | $23.86 | $74K | 143,618 |
| 2021-05-06 | Ali-Jackson Kamil Chief Legal Officer | Option exercise · Employee Stock Option (Right to Buy) | −15,000 | 5,416 |
Page 30 of 34 · 680 trades